A's Bet on a Blown-Out Elbow With First-Round Stuff

By Vinnie the Gooch·2 min read
A's Bet on a Blown-Out Elbow With First-Round Stuff

The Athletics just paid $865,000 for a pitcher who won't throw a competitive inning until 2027.

Jacob Dudan was supposed to be a first-round arm. The NC State right-hander led the ACC in innings pitched this spring, sitting mid-90s with a fastball that reportedly touched 99 and an upper-80s slider scouts called a swing-and-miss weapon. Then, in April, it all went sideways: 116 pitches into a start against Notre Dame, with his fastball still hitting 98 in the 8th inning, his elbow gave out. UCL tear. Tommy John surgery. Instant scratch from first-round boards to a project stashed in the 3rd round.

Jim Callis broke down the signing bonus and the scouting profile that made Dudan a name to know.

Jim Callis: 3rd-rder Jacob Dudan signs w/@Athletics for $865k (slot 83 value = $988,700). @NCStateBaseball RHP, generated some 1st-r
via @jimcallisMLB

The Athletics grabbed him anyway with the 83rd overall pick, and now they've locked him up for $865,000 — a bit under the $988,700 slot value at that spot, per Callis. That's the going rate for buying low on a rehab arm: the A's get a discount, Dudan gets a shot at pro development money now instead of gambling on a return year at NC State, and everybody understands the fine print. He's not pitching in an Oakland farm uniform any time soon.

This is the classic post-Tommy-John draft math. Teams see the swing-and-miss slider and the mid-to-upper-90s heat and figure the surgery is a speed bump, not a dead end. The tradeoff is patience — Dudan isn't expected to see game mounds again until 2027, which means the Athletics are stashing a lottery ticket in the system for over a year before they learn anything new about him.

For a rebuilding organization still trying to restock a farm system amid the relocation chaos of the Sacramento/Las Vegas era, that's not a bad risk to take on. Bonus-pool savings from underslot deals like Dudan's often get funneled elsewhere in the draft class, and if the elbow holds up, the A's could be sitting on a mid-rotation arm they got at a 3rd-round price. If it doesn't, it's $865,000 they can afford to lose.

The real evaluation window doesn't open for a while. Watch for Dudan's rehab timeline through instructional league updates over the next year, and don't expect meaningful game reps before 2027 — until then, this is a paper transaction with real upside attached.

Jacob DudanAthleticsMLB Draft